It is significant that IgA mAb has been shown to be protective for C. trachomatis in rodent studies [25,26], and likewise, IgA mAb protects against murine experimental shigellosis [27] and oral challenge of the invasive S. typhimurium [18]. Here, CD79A is linked to shigellosis.